Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Reizenstein

Showing results (121-130 of 222) with videos related to

Pageof 23
Sort By:
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapyG Mathé, P Reizenstein, M Eriguchi
Acta Medica Scandinavica|January 1, 1981
Relapse of acute myeloblastic leukemia lasting for four years. Production by leukemic cells of colony-stimulating activity and non-production of leukemia-associated inhibitorN Giannoulis, P Reizenstein, A Ost
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumorsM Musset, G Mathé, P Reizenstein
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Quality of diagnoses and cost of managing anemia in four countriesP Reizenstein, G Ljunggren, E Drougge
The American Journal of Digestive Diseases|May 1, 1970
Studies in the dumping syndrome. VI. Calcium deficiency after partial gastrectomyE Arman, L H Nilsson, P Reizenstein
British Journal of Haematology|January 1, 1980
Response to treatment in acute non-lymphatic leukaemia: prognostic value of colony forming and colony stimulating capacities of bone marrow and blood cells compared to other parametersM Beran, P Reizenstein, A M Uden
Acta Medica Scandinavica|April 1, 1974
Cellularity and cell proliferation rates in human bone marrow. 3. Sudies on bone marrow cellularity and erythrokinetics in primary and secondary polycythaemiaK O Skårberg, R Cea, P Reizenstein
Leukemia Research|January 1, 1989
Cytotoxic effects on viable human leukemic cells by combinations of lymphokine activated killer cells and monoclonal antibodiesG Vasilopoulos, A M Sjögren, P Reizenstein
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Immunotherapy versus chemotherapy of acute myeloid leukemia: response to PHA, allogeneic lymphocytes, and leukemic myeloblasts of remission lymphocytes from leukemia patientsP Reizenstein, C Ogier, A M Sjögren
Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Influence of pre-incubation with one antibody on the binding of a second by human lymphocytesF Eichler-Reiss, P Reizenstein, G Mathé
Pageof 23

Showing results (121-130 of 222) with videos related to

Sort By:
Pageof 23
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapyG Mathé, P Reizenstein, M Eriguchi
Acta Medica Scandinavica|January 1, 1981
Relapse of acute myeloblastic leukemia lasting for four years. Production by leukemic cells of colony-stimulating activity and non-production of leukemia-associated inhibitorN Giannoulis, P Reizenstein, A Ost
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumorsM Musset, G Mathé, P Reizenstein
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Quality of diagnoses and cost of managing anemia in four countriesP Reizenstein, G Ljunggren, E Drougge
The American Journal of Digestive Diseases|May 1, 1970
Studies in the dumping syndrome. VI. Calcium deficiency after partial gastrectomyE Arman, L H Nilsson, P Reizenstein
British Journal of Haematology|January 1, 1980
Response to treatment in acute non-lymphatic leukaemia: prognostic value of colony forming and colony stimulating capacities of bone marrow and blood cells compared to other parametersM Beran, P Reizenstein, A M Uden
Acta Medica Scandinavica|April 1, 1974
Cellularity and cell proliferation rates in human bone marrow. 3. Sudies on bone marrow cellularity and erythrokinetics in primary and secondary polycythaemiaK O Skårberg, R Cea, P Reizenstein
Leukemia Research|January 1, 1989
Cytotoxic effects on viable human leukemic cells by combinations of lymphokine activated killer cells and monoclonal antibodiesG Vasilopoulos, A M Sjögren, P Reizenstein
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Immunotherapy versus chemotherapy of acute myeloid leukemia: response to PHA, allogeneic lymphocytes, and leukemic myeloblasts of remission lymphocytes from leukemia patientsP Reizenstein, C Ogier, A M Sjögren
Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Influence of pre-incubation with one antibody on the binding of a second by human lymphocytesF Eichler-Reiss, P Reizenstein, G Mathé
Pageof 23